Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Liabilities and Shareholders Equity (2020 - 2024)

Historic Liabilities and Shareholders Equity for Universe Pharmaceuticals (UPC) over the last 6 years, with Q3 2025 value amounting to $69.3 billion.

  • Universe Pharmaceuticals' Liabilities and Shareholders Equity fell 9989.8% to $69.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $68022.8 billion, marking a year-over-year increase of 10.19%. This contributed to the annual value of $69.3 billion for FY2025, which is 9989.8% down from last year.
  • Per Universe Pharmaceuticals' latest filing, its Liabilities and Shareholders Equity stood at $69.3 billion for Q3 2025, which was down 9989.8% from $67953.4 billion recorded in Q3 2024.
  • Over the past 5 years, Universe Pharmaceuticals' Liabilities and Shareholders Equity peaked at $67953.4 billion during Q3 2024, and registered a low of $41.7 million during Q3 2023.
  • Over the past 5 years, Universe Pharmaceuticals' median Liabilities and Shareholders Equity value was $70.3 million (recorded in 2021), while the average stood at $8502.9 billion.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first skyrocketed by 24352182509.6% in 2021, then plummeted by 9989.8% in 2025.
  • Over the past 5 years, Universe Pharmaceuticals' Liabilities and Shareholders Equity (Quarter) stood at $70.1 million in 2021, then decreased by 15.12% to $59.5 million in 2022, then fell by 29.92% to $41.7 million in 2023, then skyrocketed by 162862060.88% to $67953.4 billion in 2024, then crashed by 99.9% to $69.3 billion in 2025.
  • Its Liabilities and Shareholders Equity was $69.3 billion in Q3 2025, compared to $67953.4 billion in Q3 2024 and $49.4 million in Q1 2024.